Shkreli, Valeant CEO set for a grilling at congressional price-hike hearing

Emily Wasserman

Vocal pricing critic Rep. Elijah Cummings (D-MD) has his chance to put some pharma execs in the hot seat. Former Turing Pharmaceuticals CEO Martin , who kicked off the latest brouhaha with an unapologetic 5,000% price increase, and Pharmaceuticals interim CEO Howard Schiller are expected next week at a on drug prices.

FiercePharma News

Share This Post

Related Articles

Leave a Reply

© 2018 Global Regulatory Science. All rights reserved. Site Admin · Entries RSS · Comments RSS